Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
+2.24M
-
Total reported value, excl. options
-
$526M
-
Value change
-
+$42.7M
-
Put/Call ratio
-
1
-
Number of buys
-
38
-
Number of sells
-
-30
-
Price
-
$18.80
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q1 2016
85 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q1 2016.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 49.8M outstanding shares and own 56.26% of the company stock.
Largest 10 shareholders include Woodford Investment Management Ltd (6.82M shares), BAUPOST GROUP LLC/MA (6.5M shares), VANGUARD GROUP INC (1.95M shares), FMR LLC (1.92M shares), BlackRock Fund Advisors (1.57M shares), OppenheimerFunds, Inc. (1.1M shares), FIRST MANHATTAN CO (1.02M shares), BlackRock Institutional Trust Company, N.A. (724K shares), Rock Springs Capital Management LP (651K shares), and STATE STREET CORP (544K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.